Similar articles

• N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer.

  Goldberg RM. Goldberg RM. Clin Colorectal Cancer. 2002 Aug;2(2):81. doi: 10.1016/S1533-0028(11)70509-6. Clin Colorectal Cancer. 2002. PMID: 12453321 Clinical Trial. No abstract available.
• Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.

  Allegra C, George T Jr, Yothers G. Allegra C, et al. J Natl Cancer Inst. 2011 Jan 5;103(1):4-5. doi: 10.1093/jnci/djq483. Epub 2010 Dec 1. J Natl Cancer Inst. 2011. PMID: 21123834 No abstract available.
• Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.

  Chang DZ, Abbruzzese JL. Chang DZ, et al. Clin Adv Hematol Oncol. 2005 May;3(5):400-4. Clin Adv Hematol Oncol. 2005. PMID: 16167013 Review. No abstract available.
• Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinoma.

  Van Cutsem E, Bajetta E, Valle J, Köhne CH, Hecht JR, Moore M, Germond C, Berg W, Chen BL, Jalava T, Lebwohl D, Meinhardt G, Laurent D, Lin E. Van Cutsem E, et al. J Clin Oncol. 2011 May 20;29(15):2004-10. doi: 10.1200/JCO.2010.29.5436. Epub 2011 Apr 4. J Clin Oncol. 2011. PMID: 21464401 Clinical Trial.
• [IFL].

  Yamazaki K, Yoshino T, Boku N. Yamazaki K, et al. Gan To Kagaku Ryoho. 2006 Jul;33(7):907-10. Gan To Kagaku Ryoho. 2006. PMID: 16835478 Review. Japanese.